QUALITY MANAGEMENT PRACTICES IN

CAPSULE MANUFACTURING

By group# 03
Submitted to: Ms. Syeda zainab
Class: Pharm-D, 4th proff
Group: A
Name: Ayman Kashif
Roll Number: JUW24544

Capsule Formulation & Development

1. Choosing Active Ingredients and Supporting Excipients
When it comes to developing capsules, one
of the first and most important steps is
selecting the right active pharmaceutical
ingredient (API). There are several key
things to consider: how well the drug
dissolves at different pH levels in the body,
whether it absorbs moisture easily, how
stable it is at various temperatures, and if it
can exist in different crystalline forms
(polymorphism). For drugs that don’t
dissolve well, techniques like solid
dispersions, lipid-based delivery systems, or nanocrystal formulations are often used to improve
how the drug is absorbed and how quickly it works. Recent findings have shown that
mesoporous silica can help keep drugs in an amorphous form, which prevents them from
crystallizing and makes them last longer.

Excipients — the inactive substances that go into a capsule — might not have therapeutic
effects, but they’re absolutely essential. They make the capsule easier to manufacture and ensure
it stays stable over time. Common examples include fillers like lactose or microcrystalline
cellulose, disintegrants like croscarmellose sodium, lubricants such as magnesium stearate, and
glidants like colloidal silicon dioxide. However, not all excipients work well with every API.
Some can cause unwanted reactions like pH-related breakdown or oxidation. That’s why it’s
important to test how the API and excipients interact early on to ensure a stable product.

2. Pre-formulation: Laying the Groundwork

Before a formulation goes into production, pre-formulation studies are done to fully understand
the API’s chemical and physical properties. These studies help predict how the drug will behave
in the body and during manufacturing. Factors like solubility, log P (partition coefficient), pKa,
melting point, polymorphism, particle size, and how well the powder flows are all considered.

To explore these traits, scientists use a

variety of tools. For example, Differential
Scanning Calorimetry (DSC) is used to study how a substance responds to heat, while Fourier
Transform Infrared Spectroscopy (FTIR) and Raman spectroscopy help detect chemical
interactions. Powder X-ray Diffraction (PXRD) helps spot any changes in the crystal structure.
These tests are important for spotting problems early—like incompatibilities or changes in
crystal form—that could affect how well the medicine works or how long it stays stable.

3. Making Sure Everything Works Together

Once the drug and excipients are selected, it’s crucial to check if they’re compatible over time.
Compatibility studies are done by storing the combination under stressful conditions like high
temperature, humidity, or strong light, often following international guidelines such as ICH
Q1A(R2). After storage, the samples are tested using tools like DSC and FTIR to see if anything
has changed in the way the components interact.
Advanced methods such as isothermal stress testing (IST) add another layer of insight when
combined with the above tools. These kinds of tests helps get a clear picture of how stable the
formulation is and guide decisions about packaging and storage. If the tests show things like
melting point shifts, disappearance of known peaks, or new chemical signals, that’s a sign
something’s gone wrong—possibly needing a change in formulation.

4. Final Thoughts
To sum it up, making a successful capsule isn’t just about combining ingredients—it’s about
understanding them in detail. From choosing the API and excipients, to running pre-formulation
tests and ensuring long-term stability, each step plays a crucial role. Using modern analytical
techniques helps catch issues early and supports the design of a reliable, effective capsule that
remains safe and effective throughout its shelf life.

By Dua Babar (221218)

In-Process Quality Control (IPQC) in Capsule Manufacturing

In the pharmaceutical industry, quality is a critical factor that directly impacts patient health and
therapeutic effectiveness. Medicines must be produced under stringent controls to ensure they are
safe, effective, and consistent from batch to batch. Among the various dosage forms available,
capsules are widely used due to their ease of administration, fast disintegration, and ability to
mask unpleasant tastes and odors. However, due to their physical nature and method of filling,
they require careful handling and monitoring during production.
In-Process Quality Control (IPQC) plays a vital role in ensuring that every step of the
manufacturing process complies with predetermined quality parameters. Unlike final quality
control, which checks finished products, IPQC involves real-time checks that help identify and
correct problems during production. This prevents major defects in the final product, reduces
waste, and ensures compliance with regulatory standards such as Good Manufacturing Practice
(GMP) guidelines.

Importance of IPQC in Pharmaceutical Manufacturing

The pharmaceutical manufacturing process involves various complex steps, each of which can
affect the quality of the final product. Without adequate monitoring, variations can occur in
weight, content, disintegration time, or appearance. These deviations can result in ineffective
treatment, patient dissatisfaction, or regulatory penalties. IPQC ensures that quality is built into
the product rather than simply tested at the end.
By implementing IPQC, manufacturers can:
 Detect errors early and minimize costly batch rejections.
 Ensure uniformity in product appearance, dosage strength, and therapeutic performance.
 Maintain compliance with international standards, enabling product export.
Increase efficiency by reducing rework and downtime caused by production errors.
IPQC is especially important in capsule manufacturing, where factors like capsule shell quality,
fill volume, sealing, and environmental conditions can significantly influence product integrity
and bioavailability.

IPQC Tests for Capsules

Appearance Check
This involves visually inspecting capsules to ensure they are
uniform in color, shape, and size. Capsules must be free
from cracks, dents, black spots, leakage, or any physical
defects. A uniform appearance is not only important for
patient acceptance but also indicates that the machines are
operating within the proper parameters. Defective capsules
can be caused by improper storage, worn-out tooling, or
incorrect machine settings.

Weight Variation
Weight variation tests help confirm that each capsule contains the correct amount of fill material.
Ten or more capsules are taken from different parts of the batch, weighed individually, and then
opened to weigh the fill contents separately. Any significant deviation from the average indicates
a problem in the filling mechanism, such as clogging, inconsistent flow of material, or machine
calibration issues. Consistent fill weight ensures accurate dosing, which is crucial for patient
safety and drug efficacy.

Moisture Content
Moisture control is essential, especially for hygroscopic
(moisture-sensitive) drugs and gelatin capsule shells,
which can become soft, sticky, or brittle in improper
humidity conditions. High moisture content can lead to
microbial growth or degradation of active ingredients.
Moisture is typically measured using the Loss on
Drying (LOD) method or Karl Fischer titration.
Acceptable moisture levels are defined based on the product's sensitivity and regulatory
requirements.

Disintegration Test
This test ensures that capsules disintegrate properly in the
gastrointestinal tract within the specified time. Capsules that
fail to disintegrate may not release the active ingredient at the
correct rate or site, leading to therapeutic failure. A USP
disintegration apparatus is used, in which capsules are placed in
a basket and submerged in simulated gastric or intestinal fluids
at body temperature (37±0.5°C). The time taken for complete
disintegration is recorded.

Uniformity of Fill Weight

While weight variation checks the net content, this test is more detailed, focusing on the fill
material specifically. Random capsules are sampled and evaluated to confirm that the fill weight
is within acceptable limits. Deviations can result in underdosing or overdosing, both of which are
serious issues in pharmaceutical therapy. Frequent fill weight checks are necessary when
working with low-dose or potent drugs.

Locking/Sealing Efficiency
Capsules are often manufactured using hard gelatin shells, which consist of two parts that must
fit and lock properly. Improper locking can result in leakage of the fill material, especially in
semi-solid or oily formulations. IPQC involves checking whether the capsules are securely
closed and occasionally performing a vacuum test or using specialized locking machines to
enhance sealing.

Dust and Foreign Matter Inspection

During capsule filling, some powder may escape and settle on machines or capsules. This dust
can pose cross-contamination risks or reduce the visual appeal of the capsules. Therefore,
capsules are routinely inspected and cleaned using compressed air or vacuum systems. Dust
control ensures product safety and hygiene, especially in multi-product facilities.

Shell Integrity
Capsule shells must maintain structural integrity throughout processing and storage. Defects such
as cracks, splits, or brittleness can occur due to improper drying, over-handling, or incorrect
humidity. Shell integrity is checked visually and by applying mild pressure to assess mechanical
resistance. Damaged capsules are discarded, and the cause is investigated.

Color Uniformity and Printing

Capsules are often color-coded and printed for identification, branding, and to avoid medication
errors. Any inconsistency in color, fading, or illegible printing can result in rejection of the batch.
Capsules are examined under proper lighting, and any variations are reported and corrected
immediately.

Metal Detection
Capsules may become contaminated with tiny metal particles from equipment wear and tear. To
avoid such contamination, metal detectors are installed in the production line. They identify and
reject any capsule containing metallic fragments, protecting consumers from physical harm and
complying with regulatory safety standards.

Benefits of IPQC
The implementation of in-process quality control in capsule manufacturing offers numerous
benefits:
 Product Consistency: Every capsule produced adheres to the same quality standards.
 Reduced Waste: Early detection of issues helps avoid large-scale batch rejection.
 Patient Safety: Consistent dosing and product integrity ensure effective therapy and
reduce adverse effects.
 Regulatory Compliance: IPQC aligns with requirements from agencies like FDA,
WHO, and EMA.
 Cost Efficiency: Minimizing errors during production lowers operational costs.
 Process Improvement: Data collected from IPQC tests can be used for process
optimization and continuous quality improvement (CQI).
By Aamna (221188)

QUALITY CONTROL TESTS FOR CAPSULES

Capsules are one of the most widely used solid dosage forms in the pharmaceutical industry,
valued for their ease of administration, patient compliance, and flexibility in formulation. To
ensure that capsules consistently meet quality standards and regulatory requirements, several
quality control (QC) tests are routinely performed. These tests evaluate parameters such as
uniformity of weight, content, disintegration, dissolution, microbial limits, and other critical
characteristics.
1. WEIGHT VARIATION
Purpose:
Weight variation tests ensure that each capsule contains a consistent amount of the intended
active pharmaceutical ingredient (API) and excipients.
Method:
 Hard Gelatin Capsules:
o Weigh 20 intact capsules individually and determine the average weight.

o Remove the contents of each capsule and weigh the empty shells individually.

o Subtract the shell weight from the gross weight to determine the net content
weight.
o Compare each net content weight with the average weight.

o The acceptable variation is usually ±7.5% for capsules weighing 300 mg or more
(as per pharmacopeial standards).
 Soft Gelatin Capsules:
o The entire capsule is weighed, and content weight is determined by carefully
cutting and removing the fill material.
Acceptance Criteria:
Most pharmacopeias (e.g., USP, BP, IP) specify that not more than two of the individual weights
deviate from the average weight by more than the permissible percentage deviation, and none
should deviate by more than twice that percentage.
2. CONTENT UNIFORMITY
Purpose:
Content uniformity testing ensures that the API is uniformly distributed among individual
capsules, particularly important when the API is potent or present in small quantities.
Method:
 Select a random sample of 10 capsules.
 Analyze the content of each capsule individually using a validated analytical method
(e.g., HPLC, UV spectrophotometry).
 Calculate the percentage of label claim in each unit.
Acceptance Criteria:
Typically, 9 of 10 units should be within 85% to 115% of the label claim. None should fall
outside 75% to 125% (USP and BP).
3. DISINTEGRATION TESTING
Purpose:
Disintegration tests determine how quickly the capsule disintegrates under simulated
physiological conditions, an essential parameter for bioavailability.
Method:
 Performed using the USP disintegration apparatus.
 Capsules are placed in baskets with mesh screens and immersed in a fluid (usually water
or simulated gastric fluid) maintained at 37 ± 2°C.
 The time taken for all particles to pass through the mesh (or for the shell to rupture) is
recorded.
Acceptance Criteria:
Capsules should disintegrate completely within the specified time limit (generally 30 minutes
unless otherwise specified).
4. DISSOLUTION TESTING
Purpose:
Dissolution testing measures the rate and extent of drug release from the capsule, ensuring that
the drug is available for absorption in the body.
Method:
 Carried out using USP Apparatus 1 (basket) or 2 (paddle) with specified dissolution
media (e.g., 0.1 N HCl).
 Temperature is maintained at 37 ± 0.5°C.
 Samples are withdrawn at specified time intervals, filtered, and analyzed using a suitable
analytical method.
Acceptance Criteria:
The amount of drug released at specified time points must meet pharmacopeial specifications
(e.g., Q = 80% in 30 minutes).
5. MICROBIAL TESTING
Purpose:
Microbial testing ensures that the product is free from harmful microorganisms that could
compromise patient safety.
Method:
 Total Aerobic Microbial Count (TAMC)
 Total Yeast and Mold Count (TYMC)
 Tests for specified pathogens (e.g., Escherichia coli, Salmonella spp., Staphylococcus
aureus).
  Tests are conducted using standard microbiological methods outlined in pharmacopeias
(USP <61>, <62>).
Acceptance Criteria:
Capsules must comply with the specified microbial limits. For non-sterile products, counts must
not exceed pharmacopeial limits, and specified pathogens must be absent.

ADDITIONAL QUALITY CONTROL TESTS

a. Moisture Content
 Excess moisture can affect capsule stability and integrity.
 Tested using Karl Fischer titration or Loss on Drying (LOD).
b. Visual Inspection
 Capsules should be free from cracks, pinholes, or defects in the shell.
 Color uniformity and printing (if applicable) should be consistent.
c. Identification and Assay
 Confirm the identity of the API using validated analytical techniques (e.g., IR
spectroscopy, HPLC).
 Quantitative assay ensures the correct amount of API is present.
d. Stability Testing
 Capsules are subjected to accelerated and real-time stability studies to ensure shelf life
and packaging adequacy.